chr1-248038356-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001385855.1(OR2L2):āc.89T>Cā(p.Ile30Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001385855.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2L2 | NM_001385855.1 | c.89T>C | p.Ile30Thr | missense_variant | 3/3 | ENST00000641771.1 | |
OR2L2 | NM_001004686.3 | c.89T>C | p.Ile30Thr | missense_variant | 2/2 | ||
OR2L13 | NM_001304535.3 | c.-18-61002T>C | intron_variant | ||||
OR2L13 | NM_175911.5 | c.-143-60295T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2L2 | ENST00000641771.1 | c.89T>C | p.Ile30Thr | missense_variant | 3/3 | NM_001385855.1 | P1 | ||
OR2L2 | ENST00000366479.4 | c.89T>C | p.Ile30Thr | missense_variant | 1/1 | P1 | |||
OR2L2 | ENST00000642011.1 | c.89T>C | p.Ile30Thr | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251082Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135702
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461188Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726968
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2022 | The c.89T>C (p.I30T) alteration is located in exon 1 (coding exon 1) of the OR2L2 gene. This alteration results from a T to C substitution at nucleotide position 89, causing the isoleucine (I) at amino acid position 30 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at